Literature DB >> 29956418

The "Biology-First" Hypothesis: Functional disorders may begin and end with biology-A scoping review.

P Enck1, N Mazurak1.   

Abstract

While it is generally accepted that gastrointestinal infections can cause functional disturbances in the upper and lower gastrointestinal tract-known as postinfectious irritable bowel syndrome (PI-IBS) and functional dyspepsia (PI-FD)-it has still not been widely recognized that such an infection can also initiate functional non-intestinal diseases, and that non-intestinal infections can provoke both intestinal and non-intestinal functional disturbances. We conducted a scoping review of the respective literature and-on the basis of these data-hypothesize that medically unexplained functional symptoms and syndromes following an infection may have a biological (genetic, endocrine, microbiological) origin, and that psychological and social factors, which may contribute to the disease "phenotype," are secondary to this biological cause. If this holds true, then the search for psychological and social theories and factors to explain why one patient develops a chronic functional disorder while another does not is-at least for postinfectious states-misleading and detracts from exploring and identifying the true origins of these essentially biological disorders. The biopsychosocial model may, as the term implies, always begin with biology, also for functional (somatoform) disorders.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  biopsychosocial model; chronic fatigue syndrome; functional dyspepsia; irritable bowel syndrome; postinfectious; somatoform disorders

Mesh:

Year:  2018        PMID: 29956418     DOI: 10.1111/nmo.13394

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

Review 1.  Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain.

Authors:  Mary-Ann Fitzcharles; Frank Petzke; Thomas R Tölle; Winfried Häuser
Journal:  Drugs       Date:  2021-11-20       Impact factor: 9.546

2.  No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.

Authors:  Kurt Hanevik; Christina Saghaug; Maren Aaland; Kristine Morch; Nina Langeland
Journal:  JGH Open       Date:  2022-03-14

3.  Identifying disrupted biological factors and patient-tailored interventions for chronic fatigue in adolescents and young adults with Q-Fever Fatigue Syndrome, Chronic Fatigue Syndrome and Juvenile Idiopathic Arthritis (QFS-study): study protocol for a randomized controlled trial with single-subject experimental case series design.

Authors:  Anouk Vroegindeweij; Joost F Swart; Jan Houtveen; Niels Eijkelkamp; Elise M van de Putte; Nico M Wulffraat; Sanne L Nijhof
Journal:  Trials       Date:  2022-08-19       Impact factor: 2.728

4.  Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study.

Authors:  Daniele Noviello; Andrea Costantino; Antonio Muscatello; Alessandra Bandera; Dario Consonni; Maurizio Vecchi; Guido Basilisco
Journal:  Neurogastroenterol Motil       Date:  2021-06-01       Impact factor: 3.960

5.  The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux During 20 Years: A US Population-Based Study.

Authors:  Rok Seon Choung; Yuri A Saito; Cathy D Schleck; William S Harmsen; Alan R Zinsmeister; Joseph A Murray; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2021-03       Impact factor: 11.104

Review 6.  Considering the potential for an increase in chronic pain after the COVID-19 pandemic.

Authors:  Daniel J Clauw; Winfried Häuser; Steven P Cohen; Mary-Ann Fitzcharles
Journal:  Pain       Date:  2020-08       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.